Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Get Rating) from a hold rating to a buy rating in a report issued on Friday. Other research analysts also recently issued research reports about the company. Benchmark reissued a buy rating and issued a $115.00 target price on shares of Amedisys in a report on Tuesday, March […]
Amedisys, Inc. (NASDAQ:AMED – Get Rating) – SVB Leerink cut their Q2 2023 earnings per share estimates for shares of Amedisys in a report issued on Thursday, January 5th. SVB Leerink analyst W. Mayo now anticipates that the health services provider will earn $1.28 per share for the quarter, down from their prior forecast of […]
Amedisys, Inc. (NASDAQ:AMED – Get Rating) – Oppenheimer lowered their FY2022 earnings per share estimates for Amedisys in a research report issued on Thursday, September 15th. Oppenheimer analyst M. Wiederhorn now expects that the health services provider will post earnings per share of $5.34 for the year, down from their prior estimate of $5.42. The […]
Bank of New York Mellon Corp boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 30.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 578,616 shares of the health services provider’s stock after acquiring an additional […]
Crossmark Global Holdings Inc. decreased its stake in Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 4.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,789 shares of the health services provider’s stock after selling 130 shares during the period. […]